3,4-Diaminopyridine structure
|
Common Name | 3,4-Diaminopyridine | ||
---|---|---|---|---|
CAS Number | 54-96-6 | Molecular Weight | 109.129 | |
Density | 1.3±0.1 g/cm3 | Boiling Point | 369.3±22.0 °C at 760 mmHg | |
Molecular Formula | C5H7N3 | Melting Point | 216-218 °C(lit.) | |
MSDS | Chinese USA | Flash Point | 204.9±9.5 °C | |
Symbol |
GHS06 |
Signal Word | Danger |
Use of 3,4-DiaminopyridineAmifampridine is a drug, predominantly in the treatment of a number of rare muscle diseases.Target: OthersAmifampridine is a drug, predominantly in the treatment of a number of rare muscle diseases. Amifampridine works by blocking potassium channel efflux in nerve terminals so that action potential duration is increased. Ca2+ channels can then be open for a longer time and allow greater acetylcholine release to stimulate muscle at the end plate. A 2005 systematic review from the Cochrane Collaboration found some data favouring its use in LEMS. Amifampridine is also used to treat many of the congenital myasthenic syndromes, particularly those with defects in choline acetyltransferase, downstream kinase 7, and those where any kind of defect causes "fast channel" behaviour of the acetylcholine receptor. From Wikipedia. |
Name | 3,4-Diaminopyridine |
---|---|
Synonym | More Synonyms |
Description | Amifampridine is a drug, predominantly in the treatment of a number of rare muscle diseases.Target: OthersAmifampridine is a drug, predominantly in the treatment of a number of rare muscle diseases. Amifampridine works by blocking potassium channel efflux in nerve terminals so that action potential duration is increased. Ca2+ channels can then be open for a longer time and allow greater acetylcholine release to stimulate muscle at the end plate. A 2005 systematic review from the Cochrane Collaboration found some data favouring its use in LEMS. Amifampridine is also used to treat many of the congenital myasthenic syndromes, particularly those with defects in choline acetyltransferase, downstream kinase 7, and those where any kind of defect causes "fast channel" behaviour of the acetylcholine receptor. From Wikipedia. |
---|---|
Related Catalog | |
References |
[1]. http://en.wikipedia.org/wiki/3,4-Diaminopyridine#cite_note-4 |
Density | 1.3±0.1 g/cm3 |
---|---|
Boiling Point | 369.3±22.0 °C at 760 mmHg |
Melting Point | 216-218 °C(lit.) |
Molecular Formula | C5H7N3 |
Molecular Weight | 109.129 |
Flash Point | 204.9±9.5 °C |
Exact Mass | 109.063995 |
PSA | 64.93000 |
LogP | -0.09 |
Vapour Pressure | 0.0±0.8 mmHg at 25°C |
Index of Refraction | 1.676 |
Water Solubility | 24 g/L (20 ºC) |
CHEMICAL IDENTIFICATION
HEALTH HAZARD DATAACUTE TOXICITY DATA
|
Symbol |
GHS06 |
---|---|
Signal Word | Danger |
Hazard Statements | H300 + H330-H311-H315-H319-H335 |
Precautionary Statements | P260-P264-P280-P284-P301 + P310-P305 + P351 + P338 |
Personal Protective Equipment | Eyeshields;Faceshields;full-face particle respirator type N100 (US);Gloves;respirator cartridge type N100 (US);type P1 (EN143) respirator filter;type P3 (EN 143) respirator cartridges |
Hazard Codes | T:Toxic |
Risk Phrases | R25;R36/37/38 |
Safety Phrases | S26-S28-S36/37/39-S45-S37/39-S28A |
RIDADR | UN 2811 6.1/PG 2 |
WGK Germany | 3 |
RTECS | US7600000 |
Packaging Group | I |
Hazard Class | 6.1 |
HS Code | 29333999 |
Precursor 9 | |
---|---|
DownStream 10 | |
HS Code | 2933399090 |
---|---|
Summary | 2933399090. other compounds containing an unfused pyridine ring (whether or not hydrogenated) in the structure. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0% |
Novel HPLC--Fluorescence methodology for the determination of methylglyoxal and glyoxal. Application to the analysis of monovarietal wines "Ribera del Guadiana".
Food Chem. 187 , 159-65, (2015) The determination and quantification of α-dicarbonyl compounds, glyoxal and methylglyoxal, in "Ribera del Guadiana" monovarietal wines (Extremadura, Spain) without sample clean-up has been carried out... |
|
Ectopic uterine tissue as a chronic pain generator.
Neuroscience 225 , 269-82, (2012) While chronic pain is a main symptom in endometriosis, the underlying mechanisms and effective therapy remain elusive. We developed an animal model enabling the exploration of ectopic endometrium as a... |
|
3-D-QSAR and docking studies on the neuronal choline transporter.
Bioorg. Med. Chem. Lett. 20 , 4870-7, (2010) The high affinity neuronal choline transporter (CHT1) is responsible for the uptake of choline into the pre-synaptic terminal of cholinergic neurons. Considering our past experience with modeling the ... |
3-Pyridinamine, 1,4-dihydro-4-imino- |
3,4-Pyridinedramine |
3,4-DIAMINOPYRIDINE FOR SYNTHESIS |
3,4-Diaminopyridin |
3,4-DAP |
3,4-diamino-pyridine |
3,4-diamino-pyridin |
3,4-Diaminopyridine |
Amifampridine |
3 4-DIAMINOPYRIDINE |
Pyridine-3,4-diamine |
pyridin-3,4-diaMine |
4,5-diaminopyridine |
3,4DIAMINOPYRIDINE |
EINECS 200-220-9 |
3,4 DI AMINO PYRIDINE |
Pyridin-3,4-diamin |
3-amino-4-pyridinylamine |
MFCD00006401 |
3,4-Pyridinediamine |
diamino-3,4pyridine |